Modeling human multi-lineage heart field development with pluripotent stem cells

Cell Stem Cell. 2022 Sep 1;29(9):1382-1401.e8. doi: 10.1016/j.stem.2022.08.007.

Abstract

The cardiomyocyte (CM) subtypes in the mammalian heart derive from distinct lineages known as the first heart field (FHF), the anterior second heart field (aSHF), and the posterior second heart field (pSHF) lineages that are specified during gastrulation. We modeled human heart field development from human pluripotent stem cells (hPSCs) by using single-cell RNA-sequencing to delineate lineage specification and progression. Analyses of hPSC-derived and mouse mesoderm transcriptomes enabled the identification of distinct human FHF, aSHF, and pSHF mesoderm subpopulations. Through staged manipulation of signaling pathways identified from transcriptomics, we generated myocyte populations that display molecular characteristics of key CM subtypes. The developmental trajectory of the human cardiac lineages recapitulated that of the mouse, demonstrating conserved cardiovascular programs. These findings establish a comprehensive landscape of human embryonic cardiogenesis that provides access to a broad spectrum of cardiomyocytes for modeling congenital heart diseases and chamber-specific cardiomyopathies as well as for developing new therapies to treat them.

Keywords: cardiac mesoderm specification; cardiomyocyte subtypes; hPSC models; human and mouse comparison; human heart field development; scRNA-seq.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Embryo, Mammalian
  • Humans
  • Mammals
  • Mesoderm
  • Mice
  • Myocytes, Cardiac / metabolism
  • Pluripotent Stem Cells* / metabolism

Grants and funding